Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Basic data given (comparable to standards)

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Unnamed
Year:
1988
Reference Type:
review article or handbook
Title:
IUCLID Dataset 4-Isopropylaniline
Author:
ECB
Year:
2000
Bibliographic source:
European Chemical Bureau(ECB) European Commission
Report date:
2000

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
not applicable
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
4-isopropylaniline
EC Number:
202-797-2
EC Name:
4-isopropylaniline
Cas Number:
99-88-7
Molecular formula:
C9H13N
IUPAC Name:
4-(propan-2-yl)aniline

Test animals

Species:
rat
Sex:
male/female

Results and discussion

Effect levelsopen allclose all
Sex:
female
Dose descriptor:
LD50
Effect level:
1 030 mg/kg bw
Remarks on result:
other: rat
Sex:
male
Dose descriptor:
LD50
Effect level:
1 000 mg/kg bw
Remarks on result:
other: rat

Applicant's summary and conclusion

Conclusions:
mean value LD50 = 1015 mg/kg bw (used for classification)
Risk of cutaneous absorption. Risk of methaemoglobin formation even after skin contact (leads to increased classification).
Symptoms may be delayed.
Executive summary:

The LD50 for 4-isopropylaniline has a mean value LD50 of 1015 mg/kg bw (used for classification). Risk of cutaneous absorption. Risk of methaemoglobin formation even after skin contact (leads to increased classification). Symptoms may be delayed. The conducted study was followed the OECD guideline 402.